Global Tricuspid Valve Repair Market Report and Forecast 2024-2032

Global Tricuspid Valve Repair Market Report and Forecast 2024-2032


Global Tricuspid Valve Repair Market Outlook

The tricuspid valve repair market was valued at USD 645.3 million in 2023, driven by the increasing prevalence of tricuspid valve disorders across the globe. The market size is anticipated to grow at a CAGR of 6.1% during the forecast period of 2024-2032 to achieve a value of USD 1097.6 million by 2032.

Tricuspid Valve Repair: Introduction

Tricuspid valve repair is a surgical procedure used to treat a malfunctioning tricuspid valve in the heart. The tricuspid valve is one of the four valves in the heart, and its primary function is to ensure that blood flows in the right direction through the heart. It separates the right atrium from the right ventricle and prevents blood from flowing backward into the right atrium when the right ventricle contracts. There are risks and potential complications associated with tricuspid valve repair, and the decision to undergo surgery should be made in consultation with a cardiac surgeon based on the individual patient's condition and needs.

Key Trends in the Global Tricuspid Valve Repair Market

The tricuspid valve repair market has been experiencing significant growth and evolution in recent years. Several key trends are some key trends shaping the market:
  • Growing Incidence of Tricuspid Valve Diseases: Tricuspid valve disorders, such as tricuspid regurgitation, were on the rise due to an aging population and an increase in heart-related conditions.
  • Minimally Invasive Procedures: There was a growing trend towards minimally invasive techniques for tricuspid valve repair or replacement. These approaches offered shorter recovery times and reduced complications compared to traditional open-heart surgery.
  • Advancements in Valve Repair Techniques: Innovations in tricuspid valve repair techniques, including novel annuloplasty devices and improved imaging technologies, were enhancing the success rates of valve repair procedures.
  • Bioprosthetic Valves: The use of bioprosthetic valves (made from biological tissues) for tricuspid valve replacement gained popularity due to their durability and reduced need for long-term anticoagulation therapy.
  • Transcatheter Tricuspid Valve Interventions: Transcatheter procedures, such as transcatheter tricuspid valve repair and replacement, were emerging as viable options for high-risk patients who were not suitable candidates for open-heart surgery.
  • Rising Demand for Valve Repair Over Replacement: Cardiologists and surgeons were increasingly focusing on repairing the tricuspid valve rather than replacing it, whenever possible, to preserve the patient's native valve tissue.
Global Tricuspid Valve Repair Market Segmentations

The market can be categorized into procedure type, patient condition, approach, end user, and region.

Market Breakup by Procedure Type
  • Surgical Repair
  • Transcatheter Repair
Market Breakup by Patient Condition
  • Valvular Disease
  • Structural Abnormalities:
Market Breakup by Approach
  • Traditional
  • Minimally Invasive
Market Breakup by End User
  • Hospitals
  • Ambulatory Surgical Centers
Market Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Global Tricuspid Valve Repair Market Overview

The tricuspid valve market continues to witness significant developments and trends. There is a growing prevalence of tricuspid valve disorders, with an aging population and an increased incidence of heart-related conditions driving the demand for tricuspid valve interventions. Minimally invasive procedures remain a prominent trend, offering reduced recovery times and improved patient outcomes. Advances in repair techniques, such as innovative annuloplasty devices and enhanced imaging technologies, are further enhancing the success rates of tricuspid valve repair procedures.

Additionally, bioprosthetic valves made from biological tissues are gaining traction due to their durability and reduced need for long-term anticoagulation therapy. The market is witnessing the emergence of transcatheter procedures and a growing preference for valve repair over replacement, wherever feasible, to preserve the patient's native valve tissue. Ongoing research and development efforts, global market expansion, and collaborative initiatives among healthcare stakeholders continue to shape the tricuspid valve market's landscape. Cost-effective solutions and value-based healthcare models are also increasingly prominent, reflecting a holistic approach to optimizing patient outcomes while managing healthcare costs.

Key Players in the Global Tricuspid Valve Repair Market

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the tricuspid valve repair market are as follows:
  • Edwards Lifesciences Corporation
  • Medtronic plc.
  • Abbott Laboratories
  • Boston Scientific Corporation
  • LivaNova PLC
  • CryoLife Inc.
  • Micro Interventional Devices, Inc.
  • Neovasc Inc.
  • NaviGate Cardiac Structures Inc.
  • TTK Healthcare Limited
We at Expert Market Research always strive to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Tricuspid Valve Repair Market Overview
3.1 Global Tricuspid Valve Repair Market Historical Value (2017-2023)
3.2 Global Tricuspid Valve Repair Market Forecast Value (2024-2032)
4 Global Tricuspid Valve Repair Market Landscape
4.1 Global Tricuspid Valve Repair Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Tricuspid Valve Repair Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Drug Class
4.2.3 Analysis by Route of Administration
5 Global Tricuspid Valve Repair Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Tricuspid Valve Repair Market Segmentation
6.1 Global Tricuspid Valve Repair Market by Procedure Type
6.1.1 Market Overview
6.1.2 Surgical Repair
6.1.3 Transcatheter Repair
6.2 Global Tricuspid Valve Repair Market by Patient Condition
6.2.1 Market Overview
6.2.2 Valvular Disease
6.2.3 Structural Abnormalities
6.3 Global Tricuspid Valve Repair Market by Approach
6.3.1 Market Overview
6.3.2 Traditional
6.3.3 Minimally Invasive
6.4 Global Tricuspid Valve Repair Market by End User
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Ambulatory Surgical Centers
6.5 Global Tricuspid Valve Repair Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Tricuspid Valve Repair Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Tricuspid Valve Repair Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Tricuspid Valve Repair Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Tricuspid Valve Repair Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Tricuspid Valve Repair Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Edwards Lifesciences Corporation
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisition
17.1.5 Certifications
17.2 Medtronic plc.
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisition
17.2.5 Certifications
17.3 Abbott Laboratories
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisition
17.3.5 Certifications
17.4 Boston Scientific Corporation
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisition
17.4.5 Certifications
17.5 LivaNova PLC
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisition
17.5.5 Certifications
17.6 CryoLife Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisition
17.6.5 Certifications
17.7 Micro Interventional Devices, Inc.
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisition
17.7.5 Certifications
17.8 Neovasc Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisition
17.8.5 Certifications
17.9 NaviGate Cardiac Structures Inc.
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisition
17.9.5 Certifications
17.10 TTK Healthcare Limited
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisition
17.10.5 Certifications
18 Global Tricuspid Valve Repair Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings